Skip to content
Clinical Trial Events
DIA Europe

Talk Clinical Trials Innovation track

S0102 - Patient Involvement During the Lifecycle of Clinical Trials

Wed, Mar 19, 2025 · 8:30–9:40 AM CET Delhi Room, Congress Center Basel

About this session

This session will explore concrete actions to enhance patient involvement at different time points throughout the clinical trial life cycle. Through a multistakeholder discussion, it will cover key aspects such as integrating patient perspectives in trial design and operations, industry approaches to patient engagement, and improving informed consent processes to ensure better comprehension and accessibility.

Programme:
- 3. Generating a New Informed Consent Form Template via a Co-Creation Process: From a Legal to a Comprehensible Document — Evelijn Zeijdner
- 2. Industry perspective on reflecting patient involvement in clinical trials — Cathelijne de Gram
- 1. Patient Involvement During the Life Cycle of Clinical Trials — Monique Al
- Panel Discussion — Evelijn Zeijdner, Monique Al, Marina Malikova, Cathelijne de Gram
- 4. Developing and Implementing Strategies for Patient-Centric Biomedical Product Development — Marina Malikova

Speakers

  • Cathelijne de Gram

    Regulatory Policy Lead EMEA · Johnson & Johnson

    Speaker

  • Monique Al

    Special advisor sr · CCMO, Then Netherlands

    Speaker

  • Evelijn Zeijdner

    senior project manager · IKNL

    Speaker

  • Marina Malikova

    Executive Director of Research, Assistant Professor of Surgery · Boston University School of Medicine

    Speaker

  • Susan Bhatti

    Director EU Global Regulatory and Scientific Policy, Global Regulatory Affairs · Merck BV

    Speaker

  • Begonya Nafria

    Patient Engagement in Research Coordinator · Hospital Sant Joan de Déu Barcelona

    Chair